These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4733677)

  • 41. Uric acid kidney stones induced in rats by oxonic acid, a uricase inhibitor.
    Stavric B; Nera EA; Johnson WJ; Salem FA
    Invest Urol; 1973 Jul; 11(1):3-8. PubMed ID: 4724271
    [No Abstract]   [Full Text] [Related]  

  • 42. Reduction of niridazole by rat liver santhine oxidase.
    Morita M; Feller DR; Gillette JR
    Biochem Pharmacol; 1971 Jan; 20(1):217-26. PubMed ID: 4398316
    [No Abstract]   [Full Text] [Related]  

  • 43. A method for determining plasma levels of oxypurines.
    Hayashi TT; Gilling B
    Anal Biochem; 1970 Aug; 36(2):343-51. PubMed ID: 5452957
    [No Abstract]   [Full Text] [Related]  

  • 44. Azaguanine resistant hamster cell lines not deficient in hypoxanthine-guanine phosphoribosyl transferase.
    Morrow J; Colofiore J; Rintoul D
    J Cell Physiol; 1973 Feb; 81(1):97-100. PubMed ID: 4568377
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of colchicine and allopurinol on uricogenesis. I. Kinetics of their inhibitory action on hepatic xanthine dehydrogenase].
    Escarmís C; Bozal J; Calvet F
    Rev Esp Fisiol; 1970 Jun; 26(2):109-19. PubMed ID: 4324416
    [No Abstract]   [Full Text] [Related]  

  • 46. Mechanism of antiuric action of 4-oxy- and 4-thiopyrazolopyrimidines.
    Cartier PH; Hamet M
    Biochem Pharmacol; 1973 Dec; 22(23):3061-75. PubMed ID: 4761565
    [No Abstract]   [Full Text] [Related]  

  • 47. Xanthine oxidase inhibition: effect of an N-alkyl substituent on C-2 of the nucleus of 8-azahypoxanthine.
    Biagi G; Giorgi I; Livi O; Scartoni V; Lucacchini A
    Farmaco; 1989 Sep; 44(9):843-9. PubMed ID: 2604836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo studies on uricase activity in the rat.
    Lang F; Greger R; Deetjen P
    Pflugers Arch; 1974; 351(4):323-30. PubMed ID: 4474657
    [No Abstract]   [Full Text] [Related]  

  • 49. A novel xanthine dehydrogenase inhibitor (BOF-4272).
    Sato S; Tatsumi K; Nishino T
    Adv Exp Med Biol; 1991; 309A():135-8. PubMed ID: 1789192
    [No Abstract]   [Full Text] [Related]  

  • 50. A possible role for glass bead immobilized enzymes as therapeutic agents (immobilized uricase as enzyme therapy for hyperuricemia).
    Venter JC; Venter BR; Dixon JE; Kaplan NO
    Biochem Med; 1975 Jan; 12(1):79-91. PubMed ID: 806289
    [No Abstract]   [Full Text] [Related]  

  • 51. [Modalities of purine excretion during enzyme treatment of gout and other hyperuricemic conditions with urate oxidase].
    Royer R; Vindel J; Lamarche M; Kissel P
    Presse Med (1893); 1968 Dec; 76(49):2325-7. PubMed ID: 5737250
    [No Abstract]   [Full Text] [Related]  

  • 52. Inhibition of purine nucleoside phosphorylase by 9-(phosphonoalkyl)hypoxanthines.
    Nakamura CE; Chu SH; Stoeckler JD; Parks RE
    Biochem Pharmacol; 1986 Jan; 35(2):133-6. PubMed ID: 3080002
    [No Abstract]   [Full Text] [Related]  

  • 53. Determination of 15N isotopic enrichment and concentrations of allantoin and uric acid in urine by gas chromatography/mass spectrometry.
    Chen XB; Calder AG; Prasitkusol P; Kyle DJ; Jayasuriya MC
    J Mass Spectrom; 1998 Feb; 33(2):130-7. PubMed ID: 9487687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies with 8-azainosine, a cytotoxic nucleoside with antitumor activity.
    Bennett LL; Vail MH; Allan PW; Laster WR
    Cancer Res; 1973 Mar; 33(3):465-71. PubMed ID: 4689896
    [No Abstract]   [Full Text] [Related]  

  • 55. Nicotinic acid inhibition of uricase.
    Fitzpatrick DA; FitzGerald O; McGeeney KF
    Ir J Med Sci; 1969 Nov; 8(11):531-4. PubMed ID: 4244313
    [No Abstract]   [Full Text] [Related]  

  • 56. Non-classical inhibition of uricase by cyanide.
    Conley TG; Priest DG
    Biochem J; 1980 Jun; 187(3):733-8. PubMed ID: 6821368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 3,5-disubstituted 1,2,3,4-triazoles, 1 new class of xanthine oxidase inhibitor.
    Duggan DE; Noll RM; Baer JE; Novello FC; Baldwin JJ
    J Med Chem; 1975 Sep; 18(9):900-5. PubMed ID: 808613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of allopurinol on uric acid concentrations, xanthine oxidoreductase activity and oxidative stress in broiler chickens.
    Carro MD; Falkenstein E; Radke WJ; Klandorf H
    Comp Biochem Physiol C Toxicol Pharmacol; 2010 Jan; 151(1):12-7. PubMed ID: 19654053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PURIFICATION OF XANTHINE DEHYDROGENASE FROM DROSOPHILA MELANOGASTER.
    PARZEN SD; FOX AS
    Biochim Biophys Acta; 1964 Dec; 92():465-71. PubMed ID: 14264879
    [No Abstract]   [Full Text] [Related]  

  • 60. The competitive inhibition of uricase activity by 8-azaguanine and by 8-azaxanthine.
    NORRIS ER; ROUSH A
    Arch Biochem; 1950 Oct; 28(3):465-6. PubMed ID: 14790788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.